Adverse drug reactions (ADRs) are a major concern for patients, clinicians, and regulatory
agencies. The discovery of serious ADRs leading to substantial morbidity and mortality has …

The past decade has seen tremendous development in digital health, including in innovative
new technologies such as Electronic Health Records, telemedicine, virtual visits, wearable …

Real world evidence (RWE) and real-world data (RWD) are drawing ever-increasing
attention in the pharmaceutical industry and drug regulatory authorities (DRAs) all over the …

Introduction From 2009 to 2015, the IMI PROTECT conducted rigorous studies addressing
questions about optimal implementation and significance of disproportionality analyses …

Introduction Cocaine abuse represents a major public health concern. The social perception
of cocaine has been changing over the decades, a phenomenon closely tied to its patterns …

Pharmacovigilance improves patient safety by detecting and preventing adverse drug
events. However, challenges exist that limit adverse drug event detection, resulting in many …

Introduction Medications such as buprenorphine and methadone are effective for treating
opioid use disorder (OUD), but many patients face barriers related to treatment and access …

Despite huge technological advances in the capabilities to capture, store, link and analyse
data electronically, there has been some but limited impact on routine pharmacovigilance …

The WHODrug medicinal information dictionary is a worldwide source of global medicinal
information with the aim to facilitate the coding of medications in clinical trials as well as …

Background: Adverse drug reactions (ADRs) can occur any time someone uses a
medication. ADRs are systematically tracked and cataloged, with varying degrees of …